Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Plasma cell 1Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 24Fallopian Tube Neoplasms 20Breast Neoplasms 10Carcinoma, Ovarian Epithelial 8Sarcoma 6Neoplasms 4Neoplasm Metastasis 4Triple Negative Breast Neoplasms 3Sarcoma, Kaposi 2Sarcoma, Ewing 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Multi-centric Castleman's Disease 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell 2Leiomyosarcoma 2Hodgkin Disease 2Burkitt Lymphoma 2Acquired Immunodeficiency Syndrome 2AIDS-related Kaposi sarcoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Vaccinia 1Uterine Cervical Neoplasms 1Sarcoma, Synovial 1Rhabdomyosarcoma 1Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma 1Recurrence 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1

Interventions

liposomal doxorubicin 2Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
AIDS-related Kaposi sarcoma × liposomal doxorubicin × 1 year × Clear all
NCT05411237 2026-01-23

Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 3 Not yet recruiting
130 enrolled
Sarcoma

AIDS-related Kaposi sarcoma, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT05567601 2025-06-05

Doxil/Caelyx BE Study

Baxter Healthcare Corporation

Phase 1 Completed
36 enrolled
BreastGynecologicPlasma cellSarcoma

AIDS-related Kaposi sarcoma, Breast Neoplasms, Multiple Myeloma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡